Dermatology · Papulosquamous Disorders (Psoriasis, Lichen Planus)

A patient with moderate-to-severe plaque psoriasis is started on apremilast. Which enzyme does this drug selectively inhibit?

  • A Phosphodiesterase 4
  • B Dihydrofolate reductase
  • C Calcineurin
  • D Xanthine oxidase
Correct answer: A. Phosphodiesterase 4

Explanation

Apremilast is an oral selective phosphodiesterase 4 (PDE4) inhibitor that increases intracellular cAMP, thereby downregulating pro-inflammatory cytokines like TNF-alpha and IL-23. Dihydrofolate reductase is the enzyme inhibited by methotrexate. Calcineurin is the target of cyclosporine. Xanthine oxidase is the enzyme inhibited by allopurinol. This makes phosphodiesterase 4 the correct answer.

Reference: Katzung Basic and Clinical Pharmacology, 15th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Papulosquamous Disorders (Psoriasis, Lichen Planus) MCQs

See all Papulosquamous Disorders (Psoriasis, Lichen Planus) MCQs →